Effects of Gosha-jinki-gan, a Kampo medicine, on peripheral tissue blood flow in streptozotocin-induced diabetic rats

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 20, Issue 4, 1998, Pages 321-328

  Suzuki, Y ^a,b   Goto, K ^b   Ishige, A ^b   Komatsu, Y ^b   Kamei, J ^a  

^a HOSHI UNIVERSITY   (Japan)

^b TSUMURA AND CO   (Japan)

Author keywords

Bood flow; cGMP; Diabetic mellitus; Gosha jinki gan; Nitric oxide; Rat

Indexed keywords

CYCLIC AMP; CYCLIC GMP; GOSHAJINKIGAN; KAMPO; N(G) NITRO DEXTRO ARGININE METHYL ESTER; NITRIC OXIDE; STREPTOZOCIN; TJ 107; TJ 3022; UNCLASSIFIED DRUG;

ACONITE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DIABETES MELLITUS; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; ENZYME IMMUNOASSAY; HEMATOCRIT; MALE; MICROCIRCULATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PERIPHERAL CIRCULATION; RAT; STREPTOZOCIN DIABETES; VASODILATATION;

ANIMALS; AORTA; BLOOD GLUCOSE; CYCLIC AMP; CYCLIC GMP; DIABETES MELLITUS, EXPERIMENTAL; DRUGS, CHINESE HERBAL; ENZYME INHIBITORS; HINDLIMB; MALE; MUSCLE, SKELETAL; RATS; RATS, SPRAGUE-DAWLEY; REGIONAL BLOOD FLOW; VASODILATOR AGENTS;

EID: 0031812336     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.1998.20.4.485687     Document Type: Article

References (19)

1. Sakamoto, N., Sato, Y., Goto, Y. et al. Treatment of diabetic neuropathy with traditional oriental medicine Comparison between Gosha-jinki-gan and Mecobalamin treatment. J Jpn Diab Soc 1987, 30: 729-37.
2. Shoji, M., Sato, H., Hirai, Y. et al. Pharmacological effects of Gosha-jinki-gan-ryo extract: Effects on experimental diabetes. Folia Pharmacol Jpn 1992, 99: 143-52.
3. Nishizawa, M., Sutherland, W.H.F., Nukada, H. Gosha-jinki-gan (herbal medicine) in streptozotocin-induced diabetic neuropathy. J Neurol Sci 1995, 132: 177-81.
4. Kilo, C., Vogler, N., Williamson, J.R. Muscle capillary basement membrane changes related to aging and diabetes mellitus. Diabetes 1972, 21: 881-905.
5. Bohlen, H.G., Niggl, B.A. Arteriolar anatomical and functional abnormalities in juvenile mice with genetic or streptozotocin induced diabetic mellitus. Circ Res 1979, 45: 390-6.
6. Mayne, E.C., Briges, J.M., Weaver, J.A. Platelet adhesiveness, platelet fibrinogen, and factor VIII levels in diabetic mellitus. Diabetologia 1970, 6: 436-40.
7. Sagel, J., Colwell, J.A., Crook, L. Increased platelet aggregation in early diabetes mellitus. Ann Intern Med 1975, 82: 733-8.
8. Tesfaye, S., Melik, R., Ward, J.D. Vascular factors in diabetic neuropathy. Diabetologia 1994, 37: 847-54.
9. Mayhan, W.G., Simmons, L.K., Sharpe, G.M. Mechanism of impaired responses of cerebral arterioles during diabetes mellitus. Am J Physiol 1991, 260: H319-26.
10. Tesfamariam, B., Cohen, R.A. Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am J Physiol 1992, 263: H321-6.
11. Shikano, M., Niwa, T. Effect of Chinese medicine in diabetic patients. Biomed Thermogr 1987, 7: 177-9.
12. Kowallik, P., Schulz, R., Guth, B.D. et al. Measurement of regional mvocardial blood flow with multiple colored microspheres. Circulation 1991, 83: 974-82.
13. Takanashi, H., Akima, M. Protective effects of arbaprostil against indomethacin-induced gastric lesions in rats: Significance of maintained gastric blood flow. Jpn J Pharmacol 1992, 59: 349-55.
14. G-nitro-L-arginine methyl ester. Br J Pharmacol 1990, 101: 632-9.
15. Persson, M.G., Hedqvist, P., Gustafsson, L.E. Nerve-induced tachykinin-mediated vasodilatation in skeletal muscle is dependent on nitric oxide formation. Eur J Pharmacol 1991, 205: 295-301.
16. Wang, Y.-X., Gavras, I., Wierzba, T., Lammek, B., Gavras, H. Inhibition of nitric oxide, bradykinin, and prostagtandins in normal ruts. Hypertension 1992, 19: 11255-61.
17. 1 analogue TFC 612 on diabetic neuropathy in streptozotocin-induced diabetic rats. Diabetes 1989, 38: 832-8.
18. Ueno, Y., Koike, H., Nakamura, Y., Ochi, Y., Annoh, S., Nishio, S. Effects of beraprost sodium, a prostacyclin analogue, on diabetic neuropathy in streptozotocin-induced diabetic rats. Jpn J Pharmacol 1996, 70: 177-82.
19. Hogan, M., Cerami, A., Bucala, R. Advanced glycosylation endproducts block the antiproliferative effect of nitric oxide: Role in the vascular and renal complications of diabetes mellitus. J Clin Invest 1992, 90: 1110-5.